EN DE

MedLink International Inc (MLKNA) Fair Value & Analysis

Healthcare · US · Market cap $4.8K

MI MedLink International Inc logo MedLink International Inc MLKNA · US
Price$0.0001
Fair Value$0.0001
Upside+0.0%
Quality30/100
Watch MedLink International Inc for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 3.4% net margin
Low debt
Ranks above peers (5/8)
Narrow moat 34/100
Evidence: Medium Range $0.0001 – $0.0001 Share as image

Fair value as of: Aug 13, 2026

From 15 valuation models · updated 4 days ago

Below-average quality, currently priced close to our fair value.

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Our model range runs from $0.0001 (bear) to $0.0001 (bull), base $0.0001. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 30/100 (below-average quality) with medium evidence: read the verdict with care.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$0.0010 $0.0001 Fair Value $0.0001 Oct 2015 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range $0.0001 – $0.0010 · the $0.0001 price screens below the $0.0001 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

MedLink International Inc (MLKNA) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001, implying the stock looks roughly 0.0% fairly valued today. The Quality Score stands at 30/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, MedLink International Inc generated revenue of $6.0M at a net margin of 3.4%. It earns a return on equity of 9.4%. The stock trades on a trailing P/E of 0.0 (as of Jun 22, 2026). Fundamentals as of Aug 13, 2026

The share trades near its 52-week high, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at 0%, MLKNA screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income $0.0001 $0.0001 $0.0001 76
ROIC Compounder $0.0001 $0.0001 $0.0001 72
Growth-Adj P/E $0.0001 $0.0002 $0.0003 68
All 15 models by family
DCF Models
Owner Earnings $0.0001 $0.0001 $0.0002 31
Earnings-Based
Graham-Dodd $0.0002 $0.0003 54
Lynch FV $0.0001 $0.0002 $0.0002 50
PEG = 1.0 $0.0001 $0.0002 $0.0002 46
EPV $0.0001 $0.0001 $0.0001 59
Multiples
P/E Multiple $0.0001 $0.0001 $0.0001 63
P/S Multiple $0.0001 $0.0001 $0.0001 58
P/B Multiple $0.0001 $0.0001 $0.0001 55
EV/EBIT $0.0002 $0.0003 $0.0003 53
EV/EBITDA $0.0002 $0.0003 $0.0004 54
EV/Revenue $0.0002 $0.0002 $0.0003 43
Asset-Based
NCAV (Graham) $0.0001 $0.0001 $0.0001 50
Economic Profit
Residual Income $0.0001 $0.0001 $0.0001 76
ROIC Compounder $0.0001 $0.0001 $0.0001 72
Growth Earnings
Growth-Adj P/E $0.0001 $0.0002 $0.0003 68

Widest divergence: Earnings-Based ($0.0002) versus DCF Models ($0.0001). Highest evidence: Residual Income (76).

Notify me when MLKNA reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $6.0M
Net margin 3.4%
Return on equity 9.4%
P/E ratio 0.0 as of Jun 22, 2026
Operating margin -541%
EPS (TTM) $0.0100

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 30/100

Of which business quality 29 · Market factors (momentum, volatility) 56

Profitability 41
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 20
Balance sheet, leverage, solvency risk
Investment 49
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 40
Price trend over the last 3–12 months (market factor)
52W Momentum 33
Distance to the 52-week high (market factor)

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

MedLink International, Inc. engages in selling, implementing, and supporting software solutions that provide physician practices, laboratories, and other healthcare organizations access to clinical, administrative, and financial data.

Full company description

MedLink International, Inc. engages in selling, implementing, and supporting software solutions that provide physician practices, laboratories, and other healthcare organizations access to clinical, administrative, and financial data. The company offers MedLink iSuite EHR that automates physician activities, such as prescribing, dictating, ordering lab tests and viewing results, documenting clinical encounters, and capturing charges, among others; and MedLink IX (Information eXchange), an enterprise connectivity solution that links providers and healthcare services to achieve interoperability deployed in commercial and hospital laboratories. It also provides MedLink Lab, a Web browser based lab ordering and results portal hosted on the company's virtual cloud platform; and MedLink Connect, which allows laboratory services to utilize MedLink IX to deliver laboratory results to multiple HIS and EMR, as well as Health Information networks. MedLink International sells its products through direct sales force. The company is based in Hauppauge, New York.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2000 – FY2010 · reported fiscal years

MedLink International Inc reported revenue of $6.0M in FY2010 versus $12.0K in FY2006, a compound +372.8%/yr. Reported net income was $203K in FY2010, compounding +7.8%/yr from FY2000.

Growth Quality 50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2010)
$6.0M
Latest YoY
+1,052.3%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+177.7%
Avg. growth/yr (10Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+57.5%
Revenue +372.8%/yr
FY06 $12.0K
FY07 $280K
FY08 $94.5K
FY09 $520K
FY10 $6.0M
Net income +7.8%/yr
FY00 $96.0K
FY07 −$2.5M
FY08 −$4.4M
FY09 −$3.8M
FY10 $203K

Watch MLKNA: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "MedLink International Inc Fair Value". https://www.fairvalue-calculator.com/stock/MLKNA

Peer Group

Medical Care Facilities · 267 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 30 · Bottom 25%
Fair Value upside +0% · Above median
Return on equity (TTM) 9% · Above median
Return on assets 8% · Top 25%
Net margin (TTM) 3% · Below median
Revenue growth 0% · Below median

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/E (TTM) 0.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 33 · sector 27
FUTURE 0 · sector 23
PAST 37 · sector 29
HEALTH 100 · sector 90
DIVIDEND 0 · sector 41

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Compare MedLink International Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is MedLink International Inc (MLKNA) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of $0.0001 versus a price of $0.0001, about +0% (fairly valued).
What is the fair value of MLKNA?
Our model-based fair value for MedLink International Inc is $0.0001 (as of Aug 13, 2026), built from audited fundamentals. The current price is $0.0001.
What is the quality score of MLKNA?
MedLink International Inc has a Quality Score of 30/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of MedLink International Inc (MLKNA)?
MedLink International Inc reported trailing-twelve-month revenue of about $6.0M (latest available figure, as of Aug 13, 2026).
What is the net profit margin of MLKNA?
The net profit margin of MedLink International Inc is about 3.4%, meaning it keeps roughly 3.4% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track MedLink International Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.